1
Tarran Jones
Gregory J LaRosa, Christopher Horvath, Walter Newman, S Tarran Jones, Siobhan H O&apos Brien, Theresa O&apos Keefe: Humanized anti-CCR2 antibodies and methods of use therefor. Millennium Pharmaceuticals, Hamilton Brook Smith & Reynolds P C, February 24, 2004: US06696550 (40 worldwide citation)

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the intera ...


2
Tarran Jones
Gregory J LaRosa, Christopher Horvath, Walter Newman, S Tarran Jones, Siobhan H O&apos Brien, Theresa O&apos Keefe: Recombinant anti-CCR2 antibodies and methods of use therefor. Millennium Pharmaceuticals, Hamilton Brook Smith & Reynolds P C, April 27, 2004: US06727349 (29 worldwide citation)

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the intera ...


3
Tarran Jones
Gregory J LaRosa, Christopher Horvath, Walter Newman, S Tarran Jones, Siobhan H O Brien, Theresa O Keefe: Humanized anti-CCR2 antibodies and methods of use therefor. Millennium Pharmaceuticals, Lowrie Lando & Anastasi, January 6, 2009: US07473421 (4 worldwide citation)

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the intera ...


4
Tarran Jones
Gregory J LaRosa, Christopher Horvath, Walter Newman, S Tarran Jones, Siobhan H O Brien, Theresa O Keefe: Humanized anti-CCR2 antibodies and methods of use therefor. Millennium Pharmaceuticals, Lowrie Lando & Anastasi, October 28, 2008: US07442775 (4 worldwide citation)

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the intera ...


5
Tarran Jones
Gregory J LaRosa, Christopher Horvath, Walter Newman, S Tarran Jones, Siobhan H O Brien, Theresa O Keefe: Humanized anti-CCR2 antibodies and methods of use therefor. Millennium Pharmaceuticals, Lando & Anastasi, July 24, 2012: US08227211 (3 worldwide citation)

The present invention relates to a humanized antibody or functional fragment thereof which binds to a mammalian (e.g., human) CC-chemokine receptor 2 (CCR2) or a portion of the receptor and blocks binding of a ligand to the receptor. The invention further relates to a method of inhibiting the intera ...


6
Kirk W Todd, Johan G Ekvall, Frederick M Reed, T Scott Rowe, Christopher Horvath: System and method for identifying and controlling ophthalmic surgical devices and components. Alcon, Armando Pastrana Jr, August 4, 2009: US07568619 (293 worldwide citation)

System and method for identifying a component, such as an optical probe or pneumatic scissors, of an ophthalmic surgical device. A component of a surgical device includes an identifier, such as a RFID tag. Data from the RFID tag is transmitted to a RFID reader in the device. A controller determines ...


7
Kyle R Webb, Michael F Brownell, Christopher Horvath, Tibor Juhasz, Ronald M Kurtz, Laszlo I Nagy, Mark W Ross, Carlos G Suarez: Ocular fixation and stabilization device for ophthalmic surgical applications. IntraLase, Fulbright & Jaworski L, March 8, 2005: US06863667 (117 worldwide citation)

A disposable stabilization and applanation device for reconfiguring the cornea of an eye for ophthalmic laser surgery, includes an applanation lens that is disposed in a particular spatial position with respect to an incident laser beam. The applanation lens is inserted into the central opening of a ...


8
R Kyle Webb, Michael F Brownell, Christopher Horvath, Tibor Juhasz, Ronald M Kurtz, Laszlo I Nagy, Mark W Ross, Carlos G Suarez: Ocular fixation and stabilization device for ophthalmic surgical applications. Intralase, Connolly Bove Lodge & Hutz, March 28, 2006: US07018376 (108 worldwide citation)

A method for applanating an anterior surface of a cornea and coupling the eye to a surgical laser is disclosed. A interface is provided which has a central orifice and top and bottom surfaces. A suction ring is removably coupled to the bottom surface of the interface. The interface is positioned ove ...


9
Christopher Horvath, Ruben Zadoyan: Method and apparatus for oscillator start-up control for mode-locked laser. IntraLase, Fulbright & Jaworski L, February 17, 2004: US06693927 (78 worldwide citation)

The invention is directed to an apparatus and method for oscillator start-up control, and more particularly to an apparatus and method for overdriving a laser to obtain mode-lock operation. The oscillator with start-up control has a lasing medium mounted on a base. A laser pumping source is mounted ...


10
Tibor Juhasz, Ronald M Kurtz, Christopher Horvath, Carlos G Suarez, J Randy Alexander: Method for custom corneal corrections. Intralase, Fulbright & Jaworski L, November 18, 2003: US06648877 (75 worldwide citation)

A method for customizing corneal corrections includes superposing an imaginary reference field (grid) on the anterior surface of the cornea of an eye to divide the corneal surface into reference areas. Also, a diagnostically determined refractive power map for the cornea is created. An incising lase ...